National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area.

BACKGROUND Between 2002-2014, Guinea-Bissau had 17 national campaigns with oral polio vaccine (OPV) as well as campaigns with vitamin A supplementation (VAS), measles vaccine (MV), and H1N1-influenza vaccine. We examined the impact of these campaigns on child survival. METHODS We examined the mortality rate between day 1 and 3 years of age of all children in the study area. We used Cox models with age as underlying time to calculate adjusted mortality rate ratios (MRR) between "after-campaign" mortality and "before-campaign" mortality, adjusted for temporal change in mortality and stratified for season at risk. RESULTS Mortality was lower after OPV-only campaigns than before, the MRR for after-campaign vs. before-campaign being 0.75 (95% CI=0.67-0.85). Other campaigns did not have similar effects, the MRRs being 1.22 (1.04-1.44) for OPV+VAS campaigns, 1.39 (1.20-1.61) for VAS-only campaigns, 1.32 (1.09-1.60) for MV-with-VAS campaigns, and 1.13 (0.86-1.49) for the H1N1 campaign. Thus, all other campaigns differed significantly from the effect of OPV-only campaigns. Effects did not differ for trivalent, bivalent, or monovalent strains of OPV. With each additional campaign of OPV-only, the mortality rate declined further (MRR=0.86 (0.81-0.92) per campaign). With follow-up to 3 years of age, the number needed to treat (NNT) to save one life with campaign-OPV-only was 50 neonates. CONCLUSION OPV campaigns can have a much larger effect on child survival than otherwise assumed. Stopping OPV campaigns in low-income countries as part of the endgame for polio infection may increase child mortality.

[1]  P. Aaby,et al.  Can existing live vaccines prevent COVID-19? , 2020, Science.

[2]  P. Aaby,et al.  Stopping live vaccines after disease eradication may increase mortality. , 2020, Vaccine.

[3]  A. Rodrigues,et al.  National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials , 2018, Front. Public Health.

[4]  R. Xavier,et al.  BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. , 2018, Cell host & microbe.

[5]  A. Rodrigues,et al.  Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  P. Aaby,et al.  Beneficial Nonspecific Effects of Oral Polio Vaccine (OPV): Implications for the Cessation of OPV? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Haque,et al.  Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  L. H. Jacobsen,et al.  Campaigns with oral polio vaccine may lower mortality and create unexpected results , 2017, Vaccine.

[9]  A. Rodrigues,et al.  The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment , 2017, EBioMedicine.

[10]  P. Aaby,et al.  Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971–2010 , 2016, International journal of epidemiology.

[11]  H. Whittle,et al.  Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A Review , 2016, EBioMedicine.

[12]  P. Aaby,et al.  Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study , 2015, Open forum infectious diseases.

[13]  A. Rodrigues,et al.  The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Alan D. Lopez,et al.  Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[15]  P. Aaby,et al.  Neonatal vitamin A supplementation associated with a cluster of deaths and poor early growth in a randomised trial among low-birth-weight boys of vitamin A versus oral polio vaccine at birth , 2014, BMC Pediatrics.

[16]  P. Kofoed,et al.  Malaria Transmission in Bissau, Guinea-Bissau between 1995 and 2012: Malaria Resurgence Did Not Negatively Affect Mortality , 2014, PloS one.

[17]  R. Xavier,et al.  Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity , 2013, Journal of Innate Immunity.

[18]  Peter Aaby,et al.  A small jab - a big effect: nonspecific immunomodulation by vaccines. , 2013, Trends in immunology.

[19]  R. Xavier,et al.  Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes , 2012, Proceedings of the National Academy of Sciences.

[20]  J. Ilonen,et al.  Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media , 2011, Vaccine.

[21]  T. Sørensen,et al.  Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. , 2011, International journal of epidemiology.

[22]  H. Whittle,et al.  Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? , 2011, The Journal of infectious diseases.

[23]  Peter Aaby,et al.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial , 2010, BMJ : British Medical Journal.

[24]  Maria Yazdanbakhsh,et al.  Sex-Differential Effect on Infant Mortality of Oral Polio Vaccine Administered with BCG at Birth in Guinea-Bissau. A Natural Experiment , 2008, PloS one.

[25]  A. Rodrigues,et al.  Increased Female-Male Mortality Ratio Associated With Inactivated Polio and Diphtheria-Tetanus-Pertussis Vaccines: Observations From Vaccination Trials in Guinea-Bissau , 2007, The Pediatric infectious disease journal.

[26]  M. Sodemann,et al.  Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. , 2006, Vaccine.

[27]  M. Sodemann,et al.  Childhood mortality after oral polio immunisation campaign in Guinea-Bissau. , 2005, Vaccine.

[28]  D G Altman,et al.  Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.

[29]  H. Whittle,et al.  Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries , 1995, BMJ.